4.0 Article Proceedings Paper

Characteristics and outcomes in African American patients with decompensated heart failure

Journal

ARCHIVES OF INTERNAL MEDICINE
Volume 168, Issue 11, Pages 1152-1158

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archinte.168.11.1152

Keywords

-

Ask authors/readers for more resources

Background: Outcomes in patients with chronic heart failure vary by race. Racial differences in the characteristics and outcomes of patients with acute decompensated heart failure (ADHF) have not been well characterized. Therefore, we assessed race-related differences in presentation, treatment, in-patient experiences, and short-term mortality due to ADHF before and after accounting for known covariates. Methods: The Acute Decompensated Heart Failure National Registry database was analyzed to evaluate demographic and mortality differences in African American and white patients with ADHF entered into the database from its initiation in September 2001 to December 31, 2004. Stratified analyses by cause, age, left ventricular function, and history of heart failure subgroups were also conducted. Results: A total of 105 872 episodes of ADHF occurred in white patients and 29 862 occurred in African American patients. African American patients with ADHF were younger than white patients (mean [SD] age, 63.5 [15.4] vs 72.5 [12.5] years) and had lower mean left ventricular ejection fractions. The prevalence of hypertension, diabetes mellitus, and obesity was higher in African American patients. African American race was associated with lower in-hospital mortality after adjustment for known predictors (2.1% vs 4.5%; adjusted odds ratio [OR], 0.79; 95% confidence interval [CI], 0.72-0.87; P <.001). This association persisted for all age cohorts, was independent of the use of intravenous vasoactive drugs, and was especially present in African American patients in the nonischemic subgroup (adjusted OR, 0.74; 95% Cl, 0.57-0.96) but not the ischemic subgroup (adjusted OR, 0.91; 95% Cl, 0.76-1.09). Conclusion: In ADHF, African American race is associated with lower in-hospital mortality compared with white race, despite certain indicators of increased disease severity. Trial Registration: clinicaltrials.gov Identifier: NCT00366639.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review

Muhammad Shahzeb Khan, Aymen Ahmed, Stephen J. Greene, Mona Fiuzat, Michelle M. Kittleson, Javed Butler, George L. Bakris, Gregg C. Fonarow

Summary: Heart failure and end-stage kidney disease often coexist and worsen each other's prognosis. Patients on dialysis are at high risk, but they have been excluded from major clinical trials on heart failure, resulting in a lack of data and reliance on observational evidence. In clinical practice, heart failure treatment is often reduced or discontinued in patients with end-stage kidney disease undergoing dialysis due to safety concerns. This review discusses the available evidence, challenges, and future directions for optimizing heart failure management in these high-risk patients.

JOURNAL OF CARDIAC FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Achieving Equity in Hospital Performance Assessments Using Composite Race-Specific Measures of Risk-Standardized Readmission and Mortality Rates for Heart Failure

Amgad Mentias, Eric D. Peterson, Neil Keshvani, Dharam J. Kumbhani, Clyde W. Yancy, Alanna A. Morris, Larry A. Allen, Saket Girotra, Gregg C. Fonarow, Randall C. Starling, Paulino Alvarez, Milind Y. Desai, Peter Cram, Ambarish Pandey

Summary: This study found that using race-specific risk adjustment models can more accurately represent hospital performance for patients of Black and other races in terms of heart failure hospitalization and 30-day risk-standardized readmission rate and risk-standardized mortality rate.

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

STRONG-HF and Implementing Heart Failure Therapies: Godspeed horizontal ellipsis With Care

Javed Butler, Khawaja M. Talha, Gregg C. Fonarow

CIRCULATION (2023)

Editorial Material Cardiac & Cardiovascular Systems

Target Aortic Stenosis: A National Initiative to Improve Quality of Care and Outcomes for Patients With Aortic Stenosis

Brian R. Lindman, Gregg C. Fonarow, Gary Myers, Heather M. Alger, Christine Rutan, Katie Troll, Angeline Aringo, Melanie Shahriary, Mariell Jessup, Suzanne V. Arnold, Pinak B. Shah, Wilson Y. Szeto, Clyde W. Yancy, Catherine M. Otto

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Team-Based Virtual Nudges to Overcome Clinician Inertia in Guideline-Directed Medical Therapy for Heart Failure

Gregg C. Fonarow, Harriette G. C. Van Spall, James L. Januzzi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient Populations

Muhammad Shariq Usman, Tariq Jamal Siddiqi, Stefan D. Anker, George L. Bakris, Deepak L. Bhatt, Gerasimos Filippatos, Gregg C. Fonarow, Stephen J. Greene, James L. Januzzi, Muhammad Shahzeb Khan, Mikhail N. Kosiborod, Darren K. McGuire, Ileana L. Pina, Julio Rosenstock, Muthiah Vaduganathan, Subodh Verma, Shelley Zieroth, Javed Butler

Summary: SGLT2 inhibitors can reduce the risk of heart failure events and cardiovascular death in patients with type 2 diabetes, heart failure, and chronic kidney disease, and the effects are consistent in patients with different combinations of these diseases.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Rapid and Intensive Guideline-Directed Medical Therapy for Heart Failure Strong Impact Across Ejection Fraction Spectrum*

Gregg C. Fonarow, Stephen J. Greene

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction

Josephine Harrington, Jie-Lena Sun, Gregg C. Fonarow, Stephen B. Heitner, Punag H. Divanji, Gary Binder, Larry A. Allen, Brooke Alhanti, Clyde W. Yancy, Nancy M. Albert, Adam D. DeVore, G. Michael Felker, Stephen J. Greene

Summary: This study investigated the clinical profile and healthcare costs of US patients with heart failure who do not meet the threshold for advanced therapies. The majority of these patients have severely reduced ejection fraction (≤30%) and face increased risk of death and heart failure hospitalization despite receiving guideline-directed medical therapy.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Health Care Sciences & Services

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study

Boshu Ru, Xi Tan, Yu Liu, Kartik Kannapur, Dheepan Ramanan, Garin Kessler, Dominik Lautsch, Gregg Fonarow

Summary: This study aimed to compare different machine learning prediction models and feature construction methods to predict readmissions and worsening heart failure events (WHFEs) in patients with heart failure with reduced ejection fraction (HFrEF). The results showed that the XGBoost model with the frequency of clinical codes as features had the best discriminative ability for predicting these events.

JMIR FORMATIVE RESEARCH (2023)

Article Cardiac & Cardiovascular Systems

Patterns of Referral and Postdischarge Utilization of Cardiac Rehabilitation Among Patients Hospitalized With Heart Failure: An Analysis From the GWTG-HF Registry

Neil Keshvani, Vinayak Subramanian, Christopher A. Wrobel, Nicole Solomon, Brooke Alhanti, Stephen J. Greene, Adam D. DeVore, Clyde W. Yancy, Larry A. Allen, Gregg C. Fonarow, Ambarish Pandey

Summary: This study aimed to investigate the referral and participation rates in cardiac rehabilitation (CR) among patients with heart failure with reduced ejection fraction and evaluate the impact on survival and readmission. The results showed that referral rates have increased from 2010 to 2020, but only one in four patients were referred to CR. The participation rate in CR was low. Patients referred to CR had a lower risk of 1-year death compared to those not referred.

CIRCULATION-HEART FAILURE (2023)

Editorial Material Cardiac & Cardiovascular Systems

Sotagliflozin Efficacy Irrespective of Hemoglobin A1c Level

Gregg C. Fonarow, Reza Mohebi

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Bridging Treatment Implementation Gaps in Patients With Heart Failure JACC Focus Seminar 2/3

Mohamed B. Jalloh, Tauben Averbuch, Prashanth Kulkarni, Christopher B. Granger, James L. Januzzi, Faiez Zannad, Robert W. Yeh, Clyde W. Yancy, Gregg C. Fonarow, Khadijah Breathett, Michael Gibson, Harriette G. C. Van Spall

Summary: Heart failure is a leading cause of death and disability in older adults, but the implementation of guideline-directed medical therapies to reduce the burden of the disease has been suboptimal. This review discusses interventions that increase the uptake of these therapies, barriers and facilitators of implementation, conceptual frameworks in implementation science, and trial design suggestions. An evidence-to-care conceptual model is proposed to generate evidence and promote long-term implementation. By applying principles of implementation science, policymakers, researchers, and clinicians can help alleviate the burden of heart failure worldwide.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Implementing Guideline-Directed Medical Therapy for Heart Failure JACC Focus Seminar 1/3

Harsh Patolia, Muhammad Shahzeb Khan, Gregg C. Fonarow, Javed Butler, Stephen J. Greene

Summary: Despite the availability of effective medical therapy for heart failure with reduced ejection fraction, there are major gaps in its utilization. This review discusses various strategies for improving the use of these therapies and emphasizes the urgent need for better provision of appropriate treatment.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15

Anping Cai, Congyi Zheng, Jiayuan Qiu, Gregg C. Fonarow, Gregory Y. H. Lip, Yingqing Feng, Zengwu Wang

Summary: The burden of heart failure (HF) in China is expected to increase due to population ageing. However, there is limited knowledge about the prevalence of HF stages in China. Therefore, this study aimed to evaluate the prevalence of HF stages in the general Chinese population and the specific prevalence by age, sex, and urbanity. The study found that both pre-clinical and clinical HF burdens are high in China and vary by age, sex, and urbanity.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes

Arnaud D. Kaze, Gregg C. Fonarow, Justin B. Echouffo-Tcheugui

Summary: In a large cohort of adults with type 2 diabetes, the study found a significant association between cardiac autonomic neuropathy (CAN) and the risk of silent myocardial infarction (SMI). Low heart rate variability was significantly associated with an increased risk of incident SMI. Participants with CAN had a 1.9-fold greater risk of SMI.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

No Data Available